Theralase Technologies Inc. V.TLT

Part of an E-Mail from MP Today

[toade1313]

"To complete our clinical study, Theralase® is interested in raising additional equity financing and/or exploring a possible partnership."

I had hoped these were over for awhile but I guess not. Am I reading it wrong?

[fastphilly]

I got the same email. Their reaching out to previous subscribers of private placements. Hmm....

[riverrrow]

LOL.  I heard a rumour that some pp participants from the last pp still haven't received their shares.

[DJDawg]

I'd like to believe that they are hedging by making a list of potential interested parties for another PP while they work on some real money investors. These PP's are so ridiculous. I always worry that RDW is not really trying that hard to get JV at this point. I think he feels that TLT is too small and weak to get any good deal compared to what he feels they should get. My worry is that

[TommyNickels]

He's likely looking for another 500,000 to a million to be able to commit to treating the last patients and to get Toxicology going for Rutherrin. 

[Yajne]

If RW is in discussion with any hedge funds for financing, I can understand his reluctance to jump in. My personal experience with hedge funds in my pre-retirement life (as part owner of a private oil service company) was that hedge funds were absolute sharks, very hard to extract any reasonable fair deal. They usually presented a proposal that would result in essentially taking half our company

[Infinity]

DJDawg,  I think you nailed it.  Our PP's every second month is letting the market know that TLT is running on fumes.  Negotiating any JV from a position of weakness is not going to work either.  I am hoping that the long delayed clinical studies are close to BTD and possibly AA.  I would be shocked if the SP does not go up.  I also think if I have warrants that I

[menoalittle]

Even though there's little doubt that it's kept a lid on the share price, it very well may turn out to have been a very prudent (maybe even savvy) way to move this all the way to BTD without doing any significant harm or long term damage to shareholder.  In fact, it might even eventually prove to have been one of the better ways to improve (or at least, preserve) shareholder value

[menoalittle]

Negotiating any JV from a position of attained BTD, the significantly increasing potential of Rutherrin, and a relatively low total outstanding share count is not only going to outweigh any position of weakness that TLT might currently be perceived being in, but it is going to MORE than compensate us extremely well for the temporary discomfort of having had our share priced capped for as long as

[StevenBirch]

Just because TLT scrapes together multiple small PPs to pay the bills doesn't mean they are negotiating from a position of weakness. The two aren't related at all IF they have the goods which we and Roger all think they do. Especially now that have got to this point so close to getting BTD, in fact unless they are denied they hold all the cards. I'm sure Roger could have had a deal

[BlueFranky]

Spot on StevenBirch! Go for the field goal on the 5?  Naw..

[DeathXray33]

"The significance of VC funding in propelling biotech companies toward commercialization is frequently underappreciated. VC investment often serves as the crucial financial backbone for these fledgling companies. An astonishing 98% of deal value (and 86% of the total number of deals) in the pharmaceutical sector is attributed to VC-backed companies. -- VC investors are known for their

[menoalittle]

>> VC investors are known for their willingness to commit substantial funds to companies that show high growth potential In other words, we'd been the "VC investors" for Theralase... lol.

[Dumbeldorfwhite]

Hahahahahaha nope u ain't reading it wrong. GL being the personal piggy bank for these guys. Must be nice hauling in 650k plus options every year.